Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
7.14
+0.31 (4.54%)
At close: Apr 7, 2026, 4:00 PM EDT
7.45
+0.31 (4.34%)
Pre-market: Apr 8, 2026, 7:20 AM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $628.39 million as of April 8, 2026. Its market cap has increased by 242.09% in one year.
Market Cap
628.39M
Enterprise Value
568.99M
1-Year Change
242.09%
Ranking
Category
Stock Price
$7.14
Market Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $628.39M, an increase of 80.99%. That is a compound annual growth rate of 12.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 628.39M | 48.89% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gyre Therapeutics | 650.16M |
| Crescent Biopharma | 643.69M |
| Allogene Therapeutics | 633.82M |
| Ocugen | 598.08M |
| Prime Medicine | 591.45M |
| MiMedx Group | 576.44M |
| Zura Bio | 574.98M |
| Zevra Therapeutics | 571.85M |